Recipharm, a global contract development and manufacturing organization (CDMO), and ProductLife Group (PLG), a global provider product development and regulatory affairs services, have joined forces to support (bio)pharmaceutical companies in accelerating time to clinical trials and market approval while reducing supply chain, compliance, and regulatory challenges during product development.
This agreement brings together Recipharm’s fully integrated development and manufacturing capabilities across small molecules, traditional biologics and advanced therapies medicinal products (ATMPs) with PLG’s expertise in product development, regulatory affairs and market access. By combining forces, the two companies will ensure customers receive comprehensive support from early-stage development to approval and market access, which will result in earlier availability of medicines to the market.
